These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20197381)

  • 21. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.
    Nagai J; Uchida H; Matsushita Y; Yano R; Ueda M; Niwa M; Aoki J; Chun J; Ueda H
    Mol Pain; 2010 Nov; 6():78. PubMed ID: 21062487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
    Liu S; Umezu-Goto M; Murph M; Lu Y; Liu W; Zhang F; Yu S; Stephens LC; Cui X; Murrow G; Coombes K; Muller W; Hung MC; Perou CM; Lee AV; Fang X; Mills GB
    Cancer Cell; 2009 Jun; 15(6):539-50. PubMed ID: 19477432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
    Inoue M; Ma L; Aoki J; Chun J; Ueda H
    Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
    Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
    Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary tumorigenesis through LPA receptor signaling.
    Jonkers J; Moolenaar WH
    Cancer Cell; 2009 Jun; 15(6):457-9. PubMed ID: 19477423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.
    North EJ; Osborne DA; Bridson PK; Baker DL; Parrill AL
    Bioorg Med Chem; 2009 May; 17(9):3433-42. PubMed ID: 19345587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
    Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM
    J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M; Ma L; Aoki J; Ueda H
    J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autotaxin: a protein with two faces.
    Tania M; Khan MA; Zhang H; Li J; Song Y
    Biochem Biophys Res Commun; 2010 Oct; 401(4):493-7. PubMed ID: 20888793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into autotaxin: how to produce and present a lipid mediator.
    Moolenaar WH; Perrakis A
    Nat Rev Mol Cell Biol; 2011 Sep; 12(10):674-9. PubMed ID: 21915140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
    Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
    Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
    Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.